IP & Royalty Tax Planning

IP & Royalty Tax Planning Hong Kong

Hong Kong's FSIE regime and preferential IP tax treatment make it an attractive location for IP holding — if structured correctly with adequate substance. Get the IP structure right before BEPS rules catch up with you.

香港會計師公會註冊 24小時回覆 固定收費 100% 保密
免費諮詢
5% Concessionary tax rate for qualifying IP
0% WHT on royalties paid to HK company
2023 FSIE regime effective year

IP & Royalty Tax Planning

Hong Kong's FSIE regime and preferential IP tax treatment make it an attractive location for IP holding — if structured correctly with adequate substance. Get the IP structure right before BEPS rules catch up with you.

⚠️

⚠ Post-BEPS IP Structures Require Real Substance

The OECD modified nexus approach requires IP income to be linked to IP development expenditure in the same jurisdiction. "Brass plate" IP holding in HK without genuine R&D or development activity will fail the modified nexus test under the 2024 patent box rules.

常見困擾

您是否正面對以下稅務問題？

Modified Nexus Approach

Under HK's patent box (effective 2024), the concessionary 5% rate only applies to the proportion of IP income matching qualifying R&D expenditure incurred in HK.

⚠ Risk: Outsourced R&D reduces nexus fraction → higher effective rate

Royalty Withholding Tax

Royalties received from overseas payors may be subject to WHT in the payor country. HK's DTA network can reduce this — but only if the HK IP company has substance.

⚠ Risk: No DTA access → full withholding tax reduces royalty income

FSIE Passive Income Rules

From 2023, IP income received by HK companies from foreign sources is subject to FSIE — taxable unless the nexus condition or participation exemption applies.

⚠ Risk: No nexus planning → IP income brought into HK charge unexpectedly

Royalty Rate Setting

Intercompany royalty rates between the HK IP company and operating subsidiaries must be arm's length under HK TP rules.

⚠ Risk: Above-market royalty → IRD disallows deduction in HK subsidiary
適合對象

適合對象

Tech companies with HK IP holding

Software, SaaS, and technology companies holding patents, trademarks, or source code in HK.

Pharmaceutical and biotech groups

Life sciences companies with drug patents or clinical data held in HK entities.

Media and content companies

Companies holding copyrights, trademarks, or brands through HK holding vehicles.

Manufacturing groups

Groups licensing production know-how or process patents from a HK IP company to overseas factories.

服務範疇

服務範疇

IP Holding Structure Design

Design the optimal IP holding structure — pure HK, HK + offshore layer, or integrated opco/holdco — based on the type of IP, users, and FSIE/nexus requirements.

BEPS-compliant substance planning included

Patent Box Analysis

Calculate the qualifying fraction of IP income eligible for HK's 5% concessionary rate and plan R&D expenditure to maximise the fraction.

Per IRO s.20I–20N (proposed provisions)

IP Licence Agreement Review

Review intercompany IP licence agreements for arm's length royalty rates, proper BEPS-compliant DEMPE function analysis, and TP documentation.

DEMPE = development, enhancement, maintenance, protection, exploitation

WHT Reduction Planning

Map royalty payment flows against HK's DTA network to minimise withholding tax in payor jurisdictions.

Substance requirements for DTA access
服務流程

簡單、高效、專業

1

IP Asset Inventory

Map all IP assets, their legal owners, economic owners (DEMPE functions), and royalty flows.

1-2 weeks
2

Structure Analysis

Assess current structure against FSIE, nexus, and TP requirements.

1-2 weeks
3

Restructuring Plan

Design and implement optimal IP holding structure with substance plan.

4-8 weeks
4

Annual Compliance

Maintain nexus tracking, TP documentation, and FSIE filings annually.

Annual
準備好開始了嗎？ 無需承諾，隨時取消
預約免費諮詢
客戶成功案例

為真實客戶帶來真實成果

Case Study

Software company — HK IP holding restructure

HKD 1,600,000 節省
  • Source code and patents transferred to HK IP company
  • Patent box analysis: 72% qualifying fraction
  • Effective IP tax rate reduced from 16.5% to 7.2%
  • Substance plan: 3 HK R&D staff added
"We didn't realise how much HK's IP regime could save us until they ran the numbers."
C
已驗證客戶 Case Study
Case Study

Pharmaceutical group — royalty WHT reduction

HKD 2,100,000 節省
  • Royalties from 5 Asian jurisdictions consolidated via HK IP company
  • DTA access confirmed with substance analysis
  • WHT reduced from 10-15% to 0-5% per treaty
  • Annual royalty income HKD 28M
"The substance investment paid back in 8 months from WHT savings alone."
C
已驗證客戶 Case Study
★★★★★ 2,400+ 位客戶信賴我們的團隊
免費諮詢

免費專家諮詢

立即與資深稅務專家聯繫

  • 免費30分鐘初步諮詢
  • 資深註冊會計師為您服務
  • 無需承諾，隨時取消
HKICPA 註冊 24小時回覆 無需承諾

您的資料將受到嚴格保密。

選擇我們的理由

為何選擇 TAX.hk

深厚的香港稅務專業知識

我們的註冊會計師擁有15年以上香港稅務經驗，時刻掌握稅務局的最新動態。

透明固定收費

無按小時計費的意外開支。開始前清楚了解費用。

24小時回覆

我們於一個工作天內回覆所有查詢，緊急情況4小時內處理。

嚴格保密

所有客戶資料均依據嚴格的專業保密責任妥善保管。

常見問題

常見問題

快速解答您的疑問

HK introduced a patent box regime (effective from year of assessment 2023/24) under which profits derived from qualifying IP assets (patents, plant variety rights, copyright in software) are taxed at a preferential 5% rate (vs standard 16.5%) — but only on the proportion matching R&D expenditure incurred in HK under the modified nexus approach.
Qualifying IP income includes royalties, licensing fees, embedded IP income in product sales (if separately identifiable), and gains from IP disposal. Brand income (trademarks) does NOT qualify under HK's patent box. Only patents, copyrighted software, and plant variety rights qualify.
From 1 January 2023, specified foreign-source passive income (dividends, interest, disposal gains, and IP income) received by HK companies is taxable in HK unless an exemption applies. For IP income, the exemption requires the HK entity to satisfy the economic substance or nexus requirements.
Post-BEPS, an IP holding company needs: (1) adequate employees with relevant skills in HK, (2) meaningful R&D or DEMPE activities conducted in HK or by qualifying contract R&D, (3) management and control in HK, and (4) arm's length royalty arrangements. "Brass plate" structures no longer work.
DEMPE stands for Development, Enhancement, Maintenance, Protection, and Exploitation of IP. Under BEPS Action 8-10, the right to IP income follows the entity performing DEMPE functions with substance — not legal ownership. A HK IP company must perform meaningful DEMPE functions to justify its IP income allocation.
Royalty rates must be arm's length — comparable to what unrelated parties would agree for the same IP under similar conditions. Benchmarking methods include the CUP method (if comparable licenses exist), the profit split method, or the residual profit split. We conduct a formal TP benchmarking study to set and defend the rate.

準備好開始了嗎？

立即預約資深香港稅務專家的免費諮詢。

預約免費諮詢 查看我們的顧問
探索更多

相關服務

R&D Tax Incentives Companies with R&D Expenditure in Hong Kong
FSIE Regime Specialist MNE Groups with HK Passive Income Structures
Related Party Transaction Tax Companies with Intercompany & Related Party Dealings
BEPS Pillar Two Compliance Large MNC Groups with HK Operations Above EUR 750M Threshold

本頁面僅提供一般資訊。如需針對您個人情況的建議，請諮詢合資格的香港稅務專業人士。